Dr Akhil Santhosh
@tuttsakhil
Followers
821
Following
2K
Media
162
Statuses
2K
Specialist Med Onc (MVRCCRI) DM Med onc, AIIMS Delhi(Gold Medal) MD Medicine PGIMER MBBS JIPMER MRCP UK SCE onco ECMO ASCO IDEA Winner 2025 Husband to Gopika
Calicut, Kerala.
Joined December 2023
Honoured and privileged to receive the ASCO 2025 International Development Education Award (IDEA). Grateful to all my teachers and mentors who made this happen. @MVRCancerCentre @aiims_newdelhi @oncologistindia @stolaney1 @ConquerCancerFd @ASCO
11
1
65
Successful full-dose rechallenge after fruquintinib-associated posterior reversible encephalopathy syndrome - European Journal of Cancer.
1
0
2
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial - European Journal of Cancer.
1
0
2
Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors - European Journal of Cancer.
0
4
18
Integrating Tissue and Liquid Biopsy Comprehensive Genomic Profiling to Predict Efficacy of anti-EGFR Therapies in Metastatic Colorectal Cancer: Findings From the CAPRI-2 GOIM Study - European Journal of Cancer.
1
2
12
The Association between Pretreatment Emotional Distress and Response to Tumor-infiltrating Lymphocyte Therapy in Advanced Melanoma - European Journal of Cancer
0
0
2
RT @OncoDailyIO: Small RCT Showing OS Benefit of Chemoradiotherapy plus Immunotherapy vs Observation in Resected GB/EHC - @NiuSanford.@tutt….
0
1
0
Palliative systemic therapy for locally advanced or metastatic salivary duct carcinoma: A comprehensive review - Cancer Treatment Reviews.@myESMO
1
5
10
Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients – a post-hoc analysis of the PETACC 8 trial - European Journal of Cancer
0
0
0
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201 | @JCO_ASCO
0
0
1
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial @JCO_ASCO
0
0
0
Microbiome Modulation for the Treatment of Solid Neoplasms | Journal of Clinical Oncology.@JCO_ASCO
0
3
6
RT @OncoDailyGI: Long-Term Follow-Up of CM 577 in Esophageal Cancer - Akhil Santhosh (@tuttsakhil). #Cancer #GIOnc….
0
1
0
RT @OscarTahuahua: Total neoadjuvant therapy (TNT) in rectal cancer: A comprehensive review; @JAMAOnc 2025. This review summarizes TNT in L….
0
41
0
Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts -@LungCaJournal
0
0
0
Quantitative risk of underlying disease conditions for progression from monoclonal gammopathy to multiple myeloma: a nationwide cohort study @myESMO
0
0
0
Baseline D-dimers as predictive marker of efficacy of cemiplimab treatment in cutaneous squamous cell carcinoma - European Journal of Cancer.
0
1
3
TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma - European Journal of Cancer
0
0
0
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial @TheLancetOncol
0
0
0
Reducing Fluorouracil Doses in Patients With Partial Dihydropyrimidine Dehydrogenase Deficiency Is a Treatment Safety Strategy, Not a Panacea of Precision Dosing | @JCOPO_ASCO
0
1
5